Literature DB >> 11668341

A defect in central tolerance in NOD mice.

H Kishimoto1, J Sprent.   

Abstract

The predisposition of nonobese diabetic (NOD) mice to develop autoimmune disease is usually attributed to defects in peripheral tolerance mechanisms. Here, evidence is presented that NOD mice display a defect in central tolerance (negative selection) of thymocytes. Impaired central tolerance in NOD mice was most prominent in a population of semi-mature thymocytes found in the medulla. The defect was apparent in vivo as well as in vitro, was independent of IAbetag7 expression and affected both Fas-dependent and Fas-independent pathways of apoptosis; for Fas-dependent apoptosis, the defective tolerance of NOD thymocytes correlated with the strong T cell receptor-mediated up-regulation of caspase 8-homologous FLICE (Fas-associated death-domain-like interleukin 1beta-converting enzyme)-inhibitory protein. In light of these findings, disease onset in NOD mice may reflect defects in central as well as peripheral tolerance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11668341     DOI: 10.1038/ni726

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  84 in total

1.  Nasal administration of CTB-insulin induces active tolerance against autoimmune diabetes in non-obese diabetic (NOD) mice.

Authors:  C Aspord; C Thivolet
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

Review 2.  Genetic separation of the transplantation tolerance and autoimmune phenotypes in NOD mice.

Authors:  Todd Pearson; Thomas G Markees; David V Serreze; Melissa A Pierce; Linda S Wicker; Laurence B Peterson; Leonard D Shultz; John P Mordes; Aldo A Rossini; Dale L Greiner
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

3.  Up-regulation of fas and fasL pro-apoptotic genes expression in type 1 diabetes patients after autologous haematopoietic stem cell transplantation.

Authors:  G L V de Oliveira; K C R Malmegrim; A F Ferreira; R Tognon; S Kashima; C E B Couri; D T Covas; J C Voltarelli; F A de Castro
Journal:  Clin Exp Immunol       Date:  2012-06       Impact factor: 4.330

Review 4.  Historical overview of immunological tolerance.

Authors:  Ronald H Schwartz
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-04-01       Impact factor: 10.005

5.  Activation of aryl hydrocarbon receptor by TCDD prevents diabetes in NOD mice and increases Foxp3+ T cells in pancreatic lymph nodes.

Authors:  Nancy I Kerkvliet; Linda B Steppan; William Vorachek; Shannon Oda; David Farrer; Carmen P Wong; Duy Pham; Dan V Mourich
Journal:  Immunotherapy       Date:  2009-07       Impact factor: 4.196

6.  In vitro and in vivo evaluation of staphylococcal superantigen peptide antagonists.

Authors:  Govindarajan Rajagopalan; Moon M Sen; Chella S David
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

7.  Enhanced thymic selection of FoxP3+ regulatory T cells in the NOD mouse model of autoimmune diabetes.

Authors:  Markus Feuerer; Wenyu Jiang; Phillip D Holler; Ansuman Satpathy; Christopher Campbell; Molly Bogue; Diane Mathis; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-08       Impact factor: 11.205

8.  Susceptible MHC alleles, not background genes, select an autoimmune T cell reactivity.

Authors:  Thomas Stratmann; Natalia Martin-Orozco; Valérie Mallet-Designe; Laurent Poirot; Dorian McGavern; Grigoriy Losyev; Cathleen M Dobbs; Michael B A Oldstone; Kenji Yoshida; Hitoshi Kikutani; Diane Mathis; Christophe Benoist; Kathryn Haskins; Luc Teyton
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

Review 9.  Checkpoints in lymphocyte development and autoimmune disease.

Authors:  Harald von Boehmer; Fritz Melchers
Journal:  Nat Immunol       Date:  2009-12-17       Impact factor: 25.606

10.  Single-Cell Analysis of CD4 T Cells in Type 1 Diabetes: From Mouse to Man, How to Perform Mechanistic Studies.

Authors:  Siddhartha Sharma; Jeremy Pettus; Michael Gottschalk; Brian Abe; Peter Gottlieb; Luc Teyton
Journal:  Diabetes       Date:  2019-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.